AngioDynamics, Inc.

ANGONASDAQHealthcare● Active

$11.93

$-0.01(-0.08%)

Market Cap$492934477

P/E Ratio—

52W High$13.99

52W Low$8.36

Avg Volume393K

Open$11.96

Beta0.36

Overview

AngioDynamics, Inc. (ANGO) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ANGO · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

7.00

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 88%Active transactions only · RSU vesting excluded12% Sell ↓

AngioDynamics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

ANGO insider buying and selling by quarter

ANGO insider selling · ANGO insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.4M681K0

2023 Q3

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q3

2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · ANGO ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ANGO executive sell shares · ANGO board member insider trading · ANGO insider trading SEC filing

Showing 75 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Oct 21, 2025	Weiss Lawrence T SVP, Chief Legal Officer	Purchase	10,000	$11.81	$118K	93,597	Form 4
Oct 13, 2025	Trowbridge Stephen A EVP and CFO	Purchase	890	$11.16	$10K	256,629	Form 4
Oct 9, 2025	Clemmer James C President and CEO · Director	Purchase	10,000	$11.15	$112K	882,529	Form 4
Jul 19, 2025	Trowbridge Stephen A EVP and CFO	Other	2,585	$8.69	$22K	257,123	Form 4
Jul 20, 2025	Trowbridge Stephen A EVP and CFO	Other	717	$8.69	$6K	256,406	Form 4
Jul 21, 2025	Trowbridge Stephen A EVP and CFO	Other	667	$8.99	$6K	255,739	Form 4
Jul 19, 2025	Piccinini Laura SVP International	Other	1,983	$8.69	$17K	67,372	Form 4
Jul 20, 2025	Piccinini Laura SVP International	Other	616	$8.69	$5K	66,756	Form 4
Jul 19, 2025	Nighan Warren JR SVP Quality and Regulatory	Other	735	$8.69	$6K	70,431	Form 4
Jul 20, 2025	Nighan Warren JR SVP Quality and Regulatory	Other	251	$8.69	$2K	70,180	Form 4
Jul 21, 2025	Nighan Warren JR SVP Quality and Regulatory	Other	277	$8.99	$2K	69,903	Form 4
Jul 19, 2025	Clemmer James C President and CEO · Director	Other	344	$8.69	$3K	887,491	Form 4
Jul 19, 2025	Clemmer James C President and CEO · Director	Other	8,307	$8.69	$72K	879,184	Form 4
Jul 20, 2025	Clemmer James C President and CEO · Director	Other	2,982	$8.69	$26K	876,202	Form 4
Jul 20, 2025	Clemmer James C President and CEO · Director	Other	3,673	$8.99	$33K	872,529	Form 4
Jul 19, 2025	Campbell Chad Thomas SVP/GM, Vascular Access	Other	1,025	$8.69	$9K	93,051	Form 4
Jul 20, 2025	Campbell Chad Thomas SVP/GM, Vascular Access	Other	359	$8.69	$3K	92,692	Form 4
Jul 21, 2025	Campbell Chad Thomas SVP/GM, Vascular Access	Other	395	$8.99	$4K	92,297	Form 4
Jul 17, 2025	Piccinini Laura SVP International	Other	3,074	$8.74	$27K	69,355	Form 4
Jul 16, 2025	Nighan Warren JR SVP Quality and Regulatory	Award	29,349	—	—	71,166	Form 4
Jul 16, 2025	Clemmer James C President and CEO · Director	Award	206,253	—	—	887,835	Form 4
Jul 16, 2025	Weiss Lawrence T SVP, Chief Legal Officer	Award	30,900	—	—	83,597	Form 4
Jul 16, 2025	Trowbridge Stephen A EVP and CFO	Award	86,997	—	—	259,708	Form 4
Jul 16, 2025	Campbell Chad Thomas SVP/GM, Vascular Access	Award	26,268	—	—	94,076	Form 4
Jul 16, 2025	DONNELLY HOWARD W Director	Award	17,675	—	—	167,051	Form 4

Weiss Lawrence T

SVP, Chief Legal Officer

Purchase

Date

Oct 21

10,000

Price

$11.81

Value

$118K

View Form 4 on SEC.gov

Trowbridge Stephen A

EVP and CFO

Purchase

Date

Oct 13

890

Price

$11.16

Value

$10K

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Purchase

Date

Oct 9

10,000

Price

$11.15

Value

$112K

View Form 4 on SEC.gov

Trowbridge Stephen A

EVP and CFO

Other

Date

Jul 19

2,585

Price

$8.69

Value

$22K

View Form 4 on SEC.gov

Trowbridge Stephen A

EVP and CFO

Other

Date

Jul 20

717

Price

$8.69

Value

$6K

View Form 4 on SEC.gov

Trowbridge Stephen A

EVP and CFO

Other

Date

Jul 21

667

Price

$8.99

Value

$6K

View Form 4 on SEC.gov

Piccinini Laura

SVP International

Other

Date

Jul 19

1,983

Price

$8.69

Value

$17K

View Form 4 on SEC.gov

Piccinini Laura

SVP International

Other

Date

Jul 20

616

Price

$8.69

Value

$5K

View Form 4 on SEC.gov

Nighan Warren JR

SVP Quality and Regulatory

Other

Date

Jul 19

735

Price

$8.69

Value

$6K

View Form 4 on SEC.gov

Nighan Warren JR

SVP Quality and Regulatory

Other

Date

Jul 20

251

Price

$8.69

Value

$2K

View Form 4 on SEC.gov

Nighan Warren JR

SVP Quality and Regulatory

Other

Date

Jul 21

277

Price

$8.99

Value

$2K

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Other

Date

Jul 19

344

Price

$8.69

Value

$3K

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Other

Date

Jul 19

8,307

Price

$8.69

Value

$72K

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Other

Date

Jul 20

2,982

Price

$8.69

Value

$26K

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Other

Date

Jul 20

3,673

Price

$8.99

Value

$33K

View Form 4 on SEC.gov

Campbell Chad Thomas

SVP/GM, Vascular Access

Other

Date

Jul 19

1,025

Price

$8.69

Value

$9K

View Form 4 on SEC.gov

Campbell Chad Thomas

SVP/GM, Vascular Access

Other

Date

Jul 20

359

Price

$8.69

Value

$3K

View Form 4 on SEC.gov

Campbell Chad Thomas

SVP/GM, Vascular Access

Other

Date

Jul 21

395

Price

$8.99

Value

$4K

View Form 4 on SEC.gov

Piccinini Laura

SVP International

Other

Date

Jul 17

3,074

Price

$8.74

Value

$27K

View Form 4 on SEC.gov

Nighan Warren JR

SVP Quality and Regulatory

Award

Date

Jul 16

29,349

Price

—

Value

—

View Form 4 on SEC.gov

Clemmer James C

President and CEO · Director

Award

Date

Jul 16

206,253

Price

—

Value

—

View Form 4 on SEC.gov

Weiss Lawrence T

SVP, Chief Legal Officer

Award

Date

Jul 16

30,900

Price

—

Value

—

View Form 4 on SEC.gov

Trowbridge Stephen A

EVP and CFO

Award

Date

Jul 16

86,997

Price

—

Value

—

View Form 4 on SEC.gov

Campbell Chad Thomas

SVP/GM, Vascular Access

Award

Date

Jul 16

26,268

Price

—

Value

—

View Form 4 on SEC.gov

DONNELLY HOWARD W

Director

Award

Date

Jul 16

17,675

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ANGO insider trading

ANGO insider trades

AngioDynamics, Inc. (ANGO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Clemmer James C (President and CEO · Director), Trowbridge Stephen A (EVP and CFO), Piccinini Laura (SVP International). Over the past 12 months, 5 insiders have filed transactions with the SEC. ANGO insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For AngioDynamics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

ANGO insider trading · 5 questions

The insiders of AngioDynamics, Inc. (ANGO) include executives and directors such as Clemmer James C (President and CEO · Director), Trowbridge Stephen A (EVP and CFO), Piccinini Laura (SVP International), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ANGO board member insider tradingwho are ANGO insidersANGO insider rosterAngioDynamics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026